UMEWF yields 487.80% · PFE yields 6.13%● Live data
📍 UMEWF pulled ahead of the other in Year 1
Combined, UMEWF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UMEWF + PFE for your $10,000?
UMeWorld Limited, together with its subsidiaries, operates as an educational technology company with a focus on the K-12 education market in China. It offers UMFun, a cloud-based assessment and learning analytics platform that analyzes and adapts to a student's performance and personalizes the delivery of proprietary educational items in accordance with the student's learning needs. The company's platform provides standards-based instruction, practice, assessments, and productivity tools that enhance the performance of educators and students. Its products also enable educators to track student performance in real-time to address individual student learning gaps while allowing administrators to monitor student progress and measure teacher effectiveness. It serves schools, teachers, students, and parents through online and mobile platforms. The company was formerly known as AlphaRx, Inc. and changed its name to UMeWorld Limited in March 2013. UMeWorld Limited was incorporated in 1997 and is based in Causeway Bay, Hong Kong.
Full UMEWF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.